Brown Advisory Inc Kura Oncology, Inc. Transaction History

Brown Advisory Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $4.99 Million - $11.8 Million	-627,667 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $13,383 - $29,133	2,075 Added 0.33%	627,667 $6.25 Million
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $25 - $31	2 Added 0.0%	625,592 $8.6 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $388,588 - $549,820	26,345 Added 4.4%	625,590 $9.49 Million
Q2 2019 Aug 12, 2019	BUY	$14.71 - $19.79 $8.81 Million - $11.9 Million	599,245 New	599,245 $11.8 Million

187

81.9M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $529M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.